These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 24012691)
21. Remote ischemic postconditioning protects against renal ischemia/reperfusion injury by activation of T-LAK-cell-originated protein kinase (TOPK)/PTEN/Akt signaling pathway mediated anti-oxidation and anti-inflammation. Gao S; Zhu Y; Li H; Xia Z; Wu Q; Yao S; Wang T; Yuan S Int Immunopharmacol; 2016 Sep; 38():395-401. PubMed ID: 27355132 [TBL] [Abstract][Full Text] [Related]
22. Poly(ADP‑ribose) polymerase 1/2 inhibitors decrease the ubiquitination of ALC1 mediated by CHFR in breast cancer. Wang Y; Wang Y; Wang N; You L; Long F; Shao C; Wang Y; Wu J Oncol Rep; 2019 Oct; 42(4):1467-1474. PubMed ID: 31322269 [TBL] [Abstract][Full Text] [Related]
23. Chfr is required for tumor suppression and Aurora A regulation. Yu X; Minter-Dykhouse K; Malureanu L; Zhao WM; Zhang D; Merkle CJ; Ward IM; Saya H; Fang G; van Deursen J; Chen J Nat Genet; 2005 Apr; 37(4):401-6. PubMed ID: 15793587 [TBL] [Abstract][Full Text] [Related]
24. CHFR binds to and regulates MAD2 in the spindle checkpoint through its cysteine-rich domain. Keller JA; Petty EM Biochem Biophys Res Commun; 2011 Jun; 409(3):389-93. PubMed ID: 21575600 [TBL] [Abstract][Full Text] [Related]
25. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression. Privette LM; González ME; Ding L; Kleer CG; Petty EM Cancer Res; 2007 Jul; 67(13):6064-74. PubMed ID: 17596595 [TBL] [Abstract][Full Text] [Related]
26. Stabilization of HDAC1 via TCL1-pAKT-CHFR axis is a key element for NANOG-mediated multi-resistance and stem-like phenotype in immune-edited tumor cells. Woo SR; Lee HJ; Oh SJ; Kim S; Park SH; Lee J; Song KH; Kim TW Biochem Biophys Res Commun; 2018 Sep; 503(3):1812-1818. PubMed ID: 30060952 [TBL] [Abstract][Full Text] [Related]
27. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. Chaturvedi P; Sudakin V; Bobiak ML; Fisher PW; Mattern MR; Jablonski SA; Hurle MR; Zhu Y; Yen TJ; Zhou BB Cancer Res; 2002 Mar; 62(6):1797-801. PubMed ID: 11912157 [TBL] [Abstract][Full Text] [Related]
28. [Advance of study on effects of Chfr gene of mitosis prophase checkpoint--review]. Gong H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):870-4. PubMed ID: 15631682 [TBL] [Abstract][Full Text] [Related]
29. Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination. Loring GL; Christensen KC; Gerber SA; Brenner C Cell Cycle; 2008 Jan; 7(1):96-105. PubMed ID: 18202552 [TBL] [Abstract][Full Text] [Related]
30. Chfr is linked to tumour metastasis through the downregulation of HDAC1. Oh YM; Kwon YE; Kim JM; Bae SJ; Lee BK; Yoo SJ; Chung CH; Deshaies RJ; Seol JH Nat Cell Biol; 2009 Mar; 11(3):295-302. PubMed ID: 19182791 [TBL] [Abstract][Full Text] [Related]
31. Inactivation of TOPK Caused by Hyperglycemia Blocks Diabetic Heart Sensitivity to Sevoflurane Postconditioning by Impairing the PTEN/PI3K/Akt Signaling. Gao S; Wang R; Dong S; Wu J; Perek B; Xia Z; Yao S; Wang T Oxid Med Cell Longev; 2021; 2021():6657529. PubMed ID: 33986917 [TBL] [Abstract][Full Text] [Related]
32. Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors. Ogi K; Toyota M; Mita H; Satoh A; Kashima L; Sasaki Y; Suzuki H; Akino K; Nishikawa N; Noguchi M; Shinomura Y; Imai K; Hiratsuka H; Tokino T Cancer Biol Ther; 2005 Jul; 4(7):773-80. PubMed ID: 16123600 [TBL] [Abstract][Full Text] [Related]
33. The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains. Bothos J; Summers MK; Venere M; Scolnick DM; Halazonetis TD Oncogene; 2003 Oct; 22(46):7101-7. PubMed ID: 14562038 [TBL] [Abstract][Full Text] [Related]
34. CHFR-associated early G2/M checkpoint defects in breast cancer cells. Erson AE; Petty EM Mol Carcinog; 2004 Jan; 39(1):26-33. PubMed ID: 14694445 [TBL] [Abstract][Full Text] [Related]
35. CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis. He F; Ye B; Wu X; Pan J; Wang J; Wang X BMC Gastroenterol; 2023 Apr; 23(1):114. PubMed ID: 37024798 [TBL] [Abstract][Full Text] [Related]
36. CK1 is required for a mitotic checkpoint that delays cytokinesis. Johnson AE; Chen JS; Gould KL Curr Biol; 2013 Oct; 23(19):1920-6. PubMed ID: 24055157 [TBL] [Abstract][Full Text] [Related]
37. Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate. Stavridi ES; Huyen Y; Loreto IR; Scolnick DM; Halazonetis TD; Pavletich NP; Jeffrey PD Structure; 2002 Jul; 10(7):891-9. PubMed ID: 12121644 [TBL] [Abstract][Full Text] [Related]
38. Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteins. Rizkallah R; Batsomboon P; Dudley GB; Hurt MM Oncotarget; 2015 Jan; 6(3):1446-61. PubMed ID: 25575812 [TBL] [Abstract][Full Text] [Related]
39. CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis. Privette LM; Petty EM Transl Oncol; 2008 Jul; 1(2):57-64. PubMed ID: 18633460 [TBL] [Abstract][Full Text] [Related]
40. Plk1 protein phosphorylates phosphatase and tensin homolog (PTEN) and regulates its mitotic activity during the cell cycle. Choi BH; Pagano M; Dai W J Biol Chem; 2014 May; 289(20):14066-74. PubMed ID: 24706748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]